Premium
Maintenance therapy for peptic ulcer disease
Author(s) -
WORMSLEY K. G.
Publication year - 1991
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.1991.tb00747.x
Subject(s) - medicine , maintenance therapy , perforation , peptic ulcer , disease , surgery , peptic , intensive care medicine , chemotherapy , materials science , punching , metallurgy
SUMMARY Peptic ulcers tend to recur; recurrence may be associated with an increased risk of potentially lethal complications, such as haemorrhage or perforation. Therapy aims to keep ulcers in remission. Currently, the optimal maintenance therapy is long‐term, continuous administration of antisecretory drugs. More than 80% of patients remain in remission during maintenance therapy. Maintenance therapy may be required for the life of the patient, but it is acceptable to patients and is safe.